Regenxbio
RGNX
RGNX
172 hedge funds and large institutions have $1.16B invested in Regenxbio in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 69 increasing their positions, 47 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 182 → 172 (-10)
17% less capital invested
Capital invested by funds: $1.4B → $1.16B (-$239M)
27% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 30
Holders
172
Holding in Top 10
3
Calls
$4.83M
Puts
$3.02M
Top Buyers
| 1 | +$28.8M | |
| 2 | +$28.3M | |
| 3 | +$12.7M | |
| 4 |
BlackRock
New York
|
+$6.86M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$5.7M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$6.33M | |
| 3 | -$4.17M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$3.74M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$3.62M |